ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013

In Brief: House Committee Approves Funding Boost For NIH; Michigan Centers Receive $15M Gift

July 28, 1995

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

NCI Program: DOD’s TRICARE To Cover Patient Costs In NCI Prevention, Early detection Trials

September 10, 1999

NCI Cooperative Group Clinical Trials Approved

August 27, 2010